GSK's office-space overhaul part of bigger changes

GlaxoSmithKline ($GSK) employees in the Philadelphia area face big changes in the way they work as the company prepares to relocate to a new building in the Navy Yard. But those changes are only part of the U.K.-based company's operational shifts. Job cuts, compensation changes and realigned marketing strategies are just some of the others. Report

Suggested Articles

While the failure might be a missed chance at revenue, it shouldn’t hurt Ibrance’s ability to rack up sales in the metastatic setting, one exec says.

Patients receiving Bavencio actually did worse than those who got placebo, increasing the risk of death by 31%.

Seattle Genetics and Astellas’ newcomer Padcev now has what every cancer drugmaker is looking for: Randomized trial data showing it can extend lives.